MDA-5 activation by cytoplasmic double-stranded RNA impairs endothelial function and aggravates atherosclerosis
Tobias Asdonk1, Martin Steinmetz1, Alexander Krogmann1
1Department of Medicine/Cardiology, University of Bonn, Bonn, Germany.
Journal of Cellular and Molecular Medicine
|May 1, 2016
Summary
Melanoma differentiation associated gene 5 (MDA-5) activation in immune cells impairs endothelial function and worsens atherosclerosis. MDA-5 deficiency abrogates these detrimental effects on vascular health and plaque formation.
Area of Science:
- Immunology
- Vascular Biology
- Atherosclerosis Research
Background:
- Pattern recognition receptors, including retinoic acid inducible gene-I like receptors (RLRs), mediate immune responses to viral nucleic acids.
- Melanoma differentiation associated gene 5 (MDA-5) is an RLR implicated in pro-inflammatory pathways.
- The role of MDA-5 in vascular biology and its contribution to atherogenesis remain incompletely understood.
Purpose of the Study:
- To investigate the impact of MDA-5 stimulation on endothelial cell function.
- To determine the in vivo effects of MDA-5 activation on vascular health and atherosclerosis.
- To elucidate the role of MDA-5 in the development of atherosclerotic plaques.
Main Methods:
- In vitro studies using cultured human coronary artery endothelial cells (HCAEC) stimulated with polyIC (a synthetic MDA-5 agonist).
- In vivo studies involving transfection of wild-type and genetically modified mice (ApoE(-/-)/TLR3(-/-)) with polyIC.
- Assessment of endothelial function, oxidative stress, apoptosis, cell migration, and atherosclerotic plaque formation.
Main Results:
- MDA-5 stimulation in HCAECs enhanced reactive oxygen species formation, apoptosis, and pro-inflammatory cytokine release, while reducing cell migration.
- In vivo, polyIC treatment impaired endothelium-dependent vasodilation, re-endothelialization, and increased vascular oxidative stress.
- MDA-5 deficiency protected against polyIC-induced vascular dysfunction, and chronic MDA-5 stimulation aggravated atherosclerotic plaque burden in ApoE(-/-)/TLR3(-/-) mice.
Conclusions:
- MDA-5 activation directly contributes to endothelial dysfunction.
- MDA-5 plays a significant role in promoting vascular oxidative stress and impairing vascular repair mechanisms.
- MDA-5 is a key mediator in the progression of atherosclerosis, highlighting RLRs beyond TLRs as critical players in vascular disease.
Related Concept Videos
Atherosclerosis I: Introduction
1.9K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Coronary Artery Disease II: Pathophysiology
937
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
937
Peripheral Artery Disease I: Introduction
590
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
590
Coronary Artery Disease I: Introduction
1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Atherosclerosis III: Management
571
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
571

